Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR-T100 Gel in Actinic Keratosis
NCT01516515Phase 2Completed
- Sponsor
- G&E Herbal Biotechnology
- Start
- Feb 2013
- Primary completion
- Dec 2017
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SR-T100 in actinic keratosis (AK), sponsored by G&E Herbal Biotechnology. Started Feb 2013; status: completed.
02
Drugs
SR-T100
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01516515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516515.